Scientists at Wake Forest School of Medicine Identify Genetic Variation Linked to Severity of ALS
October 16, 2019
October 16, 2019
WINSTON-SALEM, North Carolina, Oct. 16 -- The Wake Forest Baptist Medical Center issued the following news release:
A discovery made several years ago in a lab researching asthma at Wake Forest School of Medicine may now have implications for the treatment of amyotrophic lateral sclerosis (ALS), a disease with no known cure and only two FDA-approved drugs to treat its progression and severity.
A study published in the current edition of the journal Neurology Neuroimmuno . . .
A discovery made several years ago in a lab researching asthma at Wake Forest School of Medicine may now have implications for the treatment of amyotrophic lateral sclerosis (ALS), a disease with no known cure and only two FDA-approved drugs to treat its progression and severity.
A study published in the current edition of the journal Neurology Neuroimmuno . . .